1. A modelling study of the budget impact of improved glycaemic control in adults with Type 1 diabetes in the UK. Issue 8 (23rd February 2019) Authors: Choudhary, P.; de Portu, S.; Delbaere, A.; Lyon, J.; Pickup, J. C. Journal: Diabetic medicine Issue: Volume 36:Issue 8(2019) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands. (2nd August 2016) Authors: Roze, S.; Duteil, E.; Smith-Palmer, J.; de Portu, S.; Valentine, W.; de Brouwer, B. F. E.; Reznik, Y.; de Valk, H. W. Journal: Journal of medical economics Issue: Volume 19:Number 8(2016) Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark. (June 2017) Authors: Roze, S.; de Portu, S.; Smith-Palmer, J.; Delbaere, A.; Valentine, W.; Ridderstråle, M. Journal: Diabetes research and clinical practice Issue: Volume 128(2017) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Issue 11 (28th May 2015) Authors: Roze, S.; Smith‐Palmer, J.; Valentine, W.; de Portu, S.; Nørgaard, K.; Pickup, J. C. Journal: Diabetic medicine Issue: Volume 32:Issue 11(2015:Nov.) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial. Issue 2 (15th January 2017) Authors: Schütz‐Fuhrmann, I.; Castañeda, J.; Reznik, Y.; Aronson, R.; Conget, I.; Liabat, S.; Runzis, S.; de Portu, S.; Cohen, O. Journal: Diabetic medicine Issue: Volume 34:Issue 2(2017) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial. Issue 2 (February 2017) Authors: Schütz‐Fuhrmann, I.; Castañeda, J.; Reznik, Y.; Aronson, R.; Conget, I.; Liabat, S.; Runzis, S.; de Portu, S.; Cohen, O. Journal: Diabetic medicine Issue: Volume 34:Issue 2(2017) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Health‐economic analysis of real‐time continuous glucose monitoring in people with Type 1 diabetes. Issue 5 (6th January 2015) Authors: Roze, S.; Saunders, R.; Brandt, A.‐S.; de Portu, S.; Papo, N. L.; Jendle, J. Journal: Diabetic medicine Issue: Volume 32:Issue 5(2015:May) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modelling potential cost savings from use of real‐time continuous glucose monitoring in pregnant women with Type 1 diabetes. Issue 12 (4th July 2019) Authors: Murphy, H. R.; Feig, D. S.; Sanchez, J. J.; de Portu, S.; Sale, A. Journal: Diabetic medicine Issue: Volume 36:Issue 12(2019) Page Start: 1652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Use of sensor‐integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real‐world study in the UK. Issue 9 (30th June 2019) Authors: Choudhary, P.; de Portu, S.; Arrieta, A.; Castañeda, J.; Campbell, F. M. Journal: Diabetic medicine Issue: Volume 36:Issue 9(2019) Page Start: 1100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗